laser eye surgery cost
Article
Lasik Surgery Hidden Costs
By John
As more and more people opt for LASIK eye surgery, the costs for the same are going down every day. But still the price might be a bit too high for many to bear. On an average one needs to pay around $1800 for the surgery of a single eye.
Thankfully one has options when it comes to pay for the operation which allows him or her to pay the total sum in installments. First let us discuss the options one has.
Most health insurances wouldn't cover LASIK operation. But some coverage plans might actually provide you with that option. If that is the case then you are really lucky. Otherwise to get insurance pay for your LASIK eye surgery you have to convince that the surgery was a medical necessity.
Quite a few companies offer special financing options just for LASIK eye surgery. The company pays for you initially, while you pay the company back in small easy installments. There are payment plans which allow you even up to five years to repay your entire loan. And that could come down to as little as $60 per month.
An alternative to the financing options is the credit card. See if it works out to your advantage by paying through your credit card.
The greatest threat of hidden costs comes from clinics who also offer schemes of financing the operation. Be absolutely sure that you don't get into a scheme where you have to make a non-refundable deposit. There is always the chance that you are deemed not eligible for the operation. Then the whole money is down the drain. Also there can be the case of you not being satisfied with the facilities the clinic has to offer and you would want to try out a different clinic. Then also you lose your deposit. Any good, proper clinic will ask for no deposit before the pre-operative talk of the patient with the doctor.
There are also those finance schemes which wouldn't cover the costs of your post-operative treatment. Sometimes the costs of post-operative treatment are significant, especially if there is a case of complication being developed after the operation. Be absolutely sure that your costs after the operation will be covered before you avail a particular financing option.
These are some of the basic financial considerations you should make before you are ready to undergo the LASIK eye surgery.
Article Source: http://www.article-outlet.com/
 |
Is Lasik Eye Surgery For You
By Linda We're a nation that's getting sick and tired of always cleaning our glasses and dealing with contact lens solutions and problems. Many of us tire of looking for where we set our glasses or the Read more... |
 |
The Importance Of Lasik Eye Surgery By Dan Are you near sighted? Or maybe you have trouble reading the book right in front of your face. Sure, you can reach for those glasses and all will come into focus. However, you're back to square one Read more... |
Related RSS Feeds
Article Title: Promedior Announces Initiation Of Phase 2a Of Anti-Fibrotic Therapeutic, PRM-151, In The Prevention Of Post-Surgical Scarring In Glaucoma Patients Release Date: Thu, 09 Sep 2010 01:00:00 PDT Description: Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced that it has initiated a Phase 2a clinical study of PRM-151 to evaluate the efficacy, safety, and tolerability of PRM-151 in preventing post-surgical scarring in glaucoma patients following glaucoma filtration surgery... |
Article Title: Can-Fite BioPharma Announces The Initiation Of Phase 3 In Dry Eye Syndrome Release Date: Wed, 08 Sep 2010 07:00:00 PDT Description: Can-Fite BioPharma Ltd (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened an Investigational New Drug application (IND) with the US-FDA for a Phase 3 study of its lead drug, CF101, in patients with moderate to severe Dry Eye Syndrome... |
Article Title: ThromboGenics Presents Positive Pooled Results From The MIVI-TRUST Phase III Program Release Date: Tue, 07 Sep 2010 00:00:00 PDT Description: ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were presented today at the EURETINA (European Society of Retina Specialists) Congress in Paris, France... |
Article Title: American Academy Of Ophthalmology Joins Forces With Middle East Africa Council Of Ophthalmology For Joint Meeting In Chicago October 16 To 19 Release Date: Mon, 06 Sep 2010 02:00:00 PDT Description: The largest and most comprehensive ophthalmic educational meeting in the world, the American Academy of Ophthalmology's (Academy) 2010 Joint Meeting in conjunction with the Middle East Africa Council of Ophthalmology (MEACO) will be taking place in Chicago, October 16 to 19... |